Assessment of Cardiovascular Disease Risk-Reference-Cited by-同舟云学术

Assessment of Cardiovascular Disease Risk

Published:2022-09 Issue:3 Volume:51 Page:483-509
ISSN:0889-8529
Container-title:Endocrinology and Metabolism Clinics of North America
language:en
Short-container-title:Endocrinology and Metabolism Clinics of North America

Author:

Goldsborough Earl,Osuji Ngozi,Blaha Michael J.

Funder

Kowa Company

American Heart Association

Novo Nordisk

Amgen

National Institutes of Health

U.S. Food and Drug Administration

Bayer Fund

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference114 articles.

1. Heart disease and stroke statistics—2019 update: a report from the American Heart Association;Benjamin;Circulation,2019

2. Global burden of cardiovascular diseases and risk factors, 1990–2019;Roth;J Am Coll Cardiol,2020

3. Estimates of global and regional premature cardiovascular mortality in 2025;Roth;Circulation,2015

4. CDC national health report: leading causes of morbidity and mortality and associated behavioral risk and protective factors—United States, 2005-2013;Johnson;MMWR Suppl,2014

5. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study;Yusuf;Lancet,2004

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atherogenic Combined Index: Validation of a Novel Predictive Lipid Biomarker for the Presence and Severity of Coronary Artery Disease;Archives of Medical Research;2024-11

2. Revealing the nature of cardiovascular disease using DERGA, a novel data ensemble refinement greedy algorithm;International Journal of Cardiology;2024-10

3. Exposure to Polypropylene Microplastics Causes Cardiomyocyte Apoptosis Through Oxidative Stress and Activation of the MAPK‐Nrf2 Signaling Pathway;Environmental Toxicology;2024-09-09

4. Protective effects of tetramethylpyrazine on myocardial ischemia/reperfusion injury involve NLRP3 inflammasome suppression by autophagy activation;Biochemical Pharmacology;2024-09

5. Classification of Coronary Artery Disease Using Radial Artery Pulse Wave Analysis via Machine Learning;2024-08-06